新入荷
再入荷
Whole-Body PET/CT Predicts Response to HER2-Targeted Therapy in Metastatic Breast Cancer Patients - SNMMI
4.2
（4件）
タイムセール
終了まで
00
00
00
999円以上お買上げで送料無料（※）
999円以上お買上げで代引き手数料無料
999円以上お買上げで代引き手数料無料
通販と店舗では販売価格や税表示が異なる場合がございます。また店頭ではすでに品切れの場合もございます。予めご了承ください。
商品詳細情報
| 管理番号 |
新品 ：9050870842
中古 ：9050870842-1 |
メーカー | eafac7c15a39b2 | 発売日 | 2025-04-16 12:28 | 定価 | 6780円 | ||
|---|---|---|---|---|---|---|---|---|---|
| カテゴリ | |||||||||
Whole-Body PET/CT Predicts Response to HER2-Targeted Therapy in Metastatic Breast Cancer Patients - SNMMI
Whole-Body PET/CT Predicts Response to HER2-Targeted Therapy in Metastatic Breast Cancer Patients - SNMMI,Comparability of Quantifying Relative Lung Ventilation with Inhaled 99mTc-Technegas and 133Xe in Patients Undergoing Evaluation for Lung Transplantation | Journal of Nuclear Medicine,18F-FDG PET/CT in left ventricular assist device infections: In-depth characterization and clinical implications - The Journal of Heart and Lung Transplantation,Role of 18F-FDG-PET/CT in the initial staging of very high-risk Ewing Sarcoma in a prospective multicentric Phase II Study: Is there still a place for bone marrow sampling? | British Journal of Cancer,CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of 89Zr-Df-IAB22M2C, a Radiolabeled Anti-CD8 Minibody | Journal of Nuclear Medicine
健康・医学の作品リスト
](https://static.mercdn.net/item/detail/orig/photos/m35724553260_1.jpg)
レディースの製品
